Key concepts in glioblastoma therapy

Jiri Bartek, Kimberly Ng, Jiri Bartek, Walter Fischer, Bob Carter, Clark C. Chen

Research output: Contribution to journalReview articlepeer-review

49 Scopus citations

Abstract

Glioblastoma is the most common form of primary brain cancer and remains one of the most aggressive forms of human cancer. Current standard of care involves maximal surgical resection followed by concurrent therapy with radiation and the DNA alkylating agent temozolomide. Despite this aggressive regimen, the median survival remains approximately 14 months. Meaningful strategies for therapeutic intervention are desperately needed. Development of such strategies will require an understanding of the therapeutic concepts that have evolved over the past three decades. This article reviews the key principles that drive the formulation of therapeutic strategies in glioblastoma. Specifically, the concepts of tumour heterogeneity, oncogene addiction, non-oncogene addiction, tumour initiating cells, tumour microenvironment, non-coding sequences and DNA damage response will be reviewed.

Original languageEnglish (US)
Pages (from-to)753-760
Number of pages8
JournalJournal of Neurology, Neurosurgery and Psychiatry
Volume83
Issue number7
DOIs
StatePublished - Jul 2012

Fingerprint Dive into the research topics of 'Key concepts in glioblastoma therapy'. Together they form a unique fingerprint.

Cite this